{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_19784", "batch_size": 200, "batch_pos": 101, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "No high-potency language or potent metaphor used.", "method": "llm_batch", "batch_id": "batch_2_12120", "batch_size": 200, "batch_pos": 55, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment does not contain a moderate verb paired with explicit scale or impact information.", "method": "llm_batch", "batch_id": "batch_3_20980", "batch_size": 200, "batch_pos": 1, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_5568", "batch_size": 200, "batch_pos": 187, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports the focus of a trial, which is a plan, not an explicit calming cue.", "method": "llm_batch", "batch_id": "batch_5_948", "batch_size": 200, "batch_pos": 183, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_18848", "batch_size": 200, "batch_pos": 121, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_17328", "batch_size": 200, "batch_pos": 110, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes the focus of a trial (part of development capability) without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_14960", "batch_size": 200, "batch_pos": 66, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
